Interview with Cüneyt Balıkçıoğlu, General Manager, Ferring Pharmaceuticals…
The company entered the Turkish market in 2005, and made important product launches in 2008. You have been General…
Address: Büyükdere Caddesi, Nurol Plaza No:255, A Blok Kat:13 Maslak 34398 Şişli İstanbul Turkey
Tel: +90 212 335 6200
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology and osteoarthritis.The company’s research activities and products are connected by a common thread focused on the provision of tailored treatments that work on the body’s own terms to enable doctors to combat numerous diseases and medical conditions.The company has gained international recognition over the last 20 years for the creation of inventive medications that improve the quality of life of children and adults all around the world.
For fifty years, they have been at the forefront of innovation in the field of naturally occurring human peptides. They have developed treatments in areas that span the human life cycle, including: reproductive health, endocrinology, gastroenterology and urology:
Ferring’s infertility treatments give infertile couples the chance to have babies
In obstetrics, Ferring helps premature children to be born healthy and without handicaps
With treatments in endocrinology, Ferring gives children the chance to overcome growth deficiencies
Ferring’s inflammatory bowel disease (IBD) treatments enable young adults with IBD to live a normal life
In urology, Ferring’s treatment for nocturia and bedwetting helps adults and children to an undisturbed night’s sleep
Ferring’s testosterone replacement treatment improves the key symptoms of low testosterone, reduces fat and improves muscle strength and mood
Ferring’s hormonal therapy for prostate cancer offers a new treatment option to men with an advanced hormone-dependent cancer
Ferring’s strength is our extensive knowledge of peptides and the role they play in the human body.
The company entered the Turkish market in 2005, and made important product launches in 2008. You have been General…
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has…
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his experience working for the largest biotech…
Şükran Tümay, a senior partner at executive search and assessment firm Stanton Chase in Turkey, highlights the…
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare…
Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on…
Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the…
Ozlem Fidanci, CEO of the Middle East and Turkey at Philips, shares the collaborative approach Philips has…
Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city…
Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing,…
Gamze Çıtıroğlu, Murat Çıtıroğlu and Pınar Çakır of Ekin Kimya discuss the progress of the Turkish…
Funda Gücer, country manager at Mylan Turkey, portrays her experience in introducing the company to the Turkish…